Anavex Life Sciences Corp
NASDAQ:AVXL

Watchlist Manager
Anavex Life Sciences Corp Logo
Anavex Life Sciences Corp
NASDAQ:AVXL
Watchlist
Price: 4.46 USD -1.33% Market Closed
Market Cap: $398.5m

Relative Value

The Relative Value of one AVXL stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.46 USD, Anavex Life Sciences Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AVXL Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

AVXL Competitors Multiples
Anavex Life Sciences Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Anavex Life Sciences Corp
NASDAQ:AVXL
385.7m USD 0 -8.5 -5.7 -5.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
401.5B USD 6.7 170.6 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
184.1B USD 5.1 26.3 18.8 18.8
US
Gilead Sciences Inc
NASDAQ:GILD
179.9B USD 6.2 22.2 15 15
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.4B USD 10.1 32.2 23.7 24.7
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD 5.6 17.8 15 17.2
AU
CSL Ltd
ASX:CSL
86.7B AUD 3.9 20.1 13.4 16.8
NL
argenx SE
XBRU:ARGX
43.5B EUR 14.5 34.2 58.4 60.1
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
US
Anavex Life Sciences Corp
NASDAQ:AVXL
Average P/S: 3 364 542.5
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.1
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
6.2
4%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.1
10%
1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
8%
0.7
AU
CSL Ltd
ASX:CSL
3.9
5%
0.8
NL
argenx SE
XBRU:ARGX
14.5
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
US
Anavex Life Sciences Corp
NASDAQ:AVXL
Average P/E: 46.2
Negative Multiple: -8.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
26.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.2
191%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
9%
2
AU
CSL Ltd
ASX:CSL
20.1
11%
1.8
NL
argenx SE
XBRU:ARGX
34.2
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Anavex Life Sciences Corp
NASDAQ:AVXL
Average EV/EBITDA: 23
Negative Multiple: -5.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.8
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
15
7%
2.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.7
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15
24%
0.6
AU
CSL Ltd
ASX:CSL
13.4
8%
1.7
NL
argenx SE
XBRU:ARGX
58.4
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Anavex Life Sciences Corp
NASDAQ:AVXL
Average EV/EBIT: 25.1
Negative Multiple: -5.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
15
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.7
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
23%
0.7
AU
CSL Ltd
ASX:CSL
16.8
11%
1.5
NL
argenx SE
XBRU:ARGX
60.1
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A